Cited by 3Philosophy and History of ScienceComputational Drug Discovery MethodsStatistical Methods in Clinical Trials

A Philosophical Framework for Integrating Systems Pharmacology Models Into Pharmacometrics

Open access
Duffull, SB·2016·CPT: Pharmacometrics & Systems Pharmacology

Abstract

The framework for systems pharmacology style models does not naturally sit with the usual scientific dogma of parsimony and falsifiability based on deductive reasoning. This does not invalidate the importance or need for overarching models based on pharmacology to describe and understand complicated biological systems. However, it does require some consideration on how systems pharmacology fits into the overall scientific approach.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/psp4.12148

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Techniques exist to establish model parameter redundancy, which alongside structural identifiability analysis can support model reparameterization or lumping if required.

    “In addition, there are also techniques available in the literature60, 61 to establish model parameter redundancy, which alongside structural identifiability analysis can support model reparameterization or lumping, should this be required.62”

    From Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network (2019) · cites this paper as [62]

    In Example 2 (page unavailable), Duffull describes an unidentifiable coagulation model that was reduced from 73 to 5 differential equations using proper lumping. The paper thus supports lumping in response to identifiability problems, but does not describe reparameterization or establish that structural identifiability analysis and parameter-redundancy techniques jointly support those steps. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 25 · Cited by 3

Research works printed but not linked: 20

  1. [1]van der Greef, J. & McBurney, R.N. Innovation: rescuing drug doscovery: in vivo systems pathology and systems pharmacology. Nat. Rev. Drug Discov. 4, 961– 967 (2005). 16341061
  2. [3]Greenland, S. Induction versus Popper: substance versus semantics. Int. J. Epidemiol. 27, 543– 548 (1998). 9758105
  3. [5]Kitano, H. Systems biology: a brief overview. Science 295, 1662– 1664 (2002). 11872829
  4. [6]Kitano, H. Computational systems biology. Nature 420, 206– 210 (2002). 12432404
  5. [7]Bies, R., Cook, S. & Duffull, S. The pharmacometrician's dilemma: the tension between mechanistic and empirical approaches in mathematical modelling and simulation – a continuation of the age‐old dispute between rationalism and empiricism? Br. J. Clin. Pharmacol. 82, 580– 582 (2016). 27292204 PMC5338100
  6. [8]Box, G.E.P. Robustness in the strategy of scientific model building. Technical Summary Report, vol. 1954, pp 1–36 (University of Wisconsin‐Madison, University of Wisconsin‐Madison Mathematics Research Center, 1979).
  7. [10]Hill, A.V. The mode of action of nicotine and curari, determined by the form of the contraction curve and the method of temperature coefficients. J. Physiol. 23, 361– 373 (1909). PMC1533665 16992989
  8. [12]Sheiner, L.B. Learning versus confirming in clincal drug development. Clin. Pharmacol. Ther. 61, 275– 291 (1997). 9084453
  9. [13]Wajima, T., Isbister, G.K. & Duffull, S.B. A comprehensive model for the humoral coagulation network in humans. Clin. Pharmacol. Ther. 86, 290– 298 (2009). 19516255
  10. [14]Ahn, J.E., Birbaum, A.K. & Brundage, R.C. Inherent correlation between dose and clearance in therapeutic drug monitoring settings: possible misinterpretation in population pharmacokinetic analyses. J. Pharmacokinet. Pharmacodyn. 32, 703– 718 (2005). 16328100
  11. [15]Lendrem, D.W. et al Teaching examples for the design of experiments: geographical sensitivity and the self‐fulfilliing prophecy. Pharm. Stat. 15, 90– 92 (2016). 26559516
  12. [16]Ma, P. Theoretical considerations of target‐mediated drug disposition models: simplifications and approximations. Pharm. Res. 29, 866– 882 (2012). 22130732
  13. [18]Mager, D.E. & Jusko, W.J. General pharmacokinetic model for drugs exhibiting target‐mediated drug disposition. J. Pharmacokinet. Pharmacodyn. 28, 507– 532 (2001). 11999290
  14. [20]Motulsky, H.J. & Mahan, L.C. The kinetics of competitive radioligand binding predicted by the law of mass action. Mol. Pharmacol. 25, 1– 9 (1984). 6708928
  15. [21]Cao, Y. & Jusko, W.J. Incorporating target‐mediated drug disposition in a minimal physiologically‐based pharmacokinetic model for monoclonal antibodies. J. Pharmacokinet. Pharmacodyn. 41, 375– 387 (2014). 25077917 PMC4167346
  16. [22]Gulati, A., Isbister, G.K. & Duffull, S.B. Scale reduction of a systems coagulation model with an application to modeling pharmacokinetic‐pharmacodynamic data. CPT Pharmacometrics Syst. Pharmacol. 3, e90 (2014). 24402117 PMC3910010
  17. [23]Gulati, A., Isbister, G.K. & Duffull, S.B. Effect of Australian elapid venoms on blood coagulation: Australian Snakebite Project (ASP‐17). Toxicon 61, 94– 104 (2013). 23151381
  18. [24]Dokoumetzidis, A. & Aarons, L. Proper lumping in systems biology models. IET Syst. Biol. 3, 40– 51 (2009). 19154083
  19. [25]Shivva, V., Tucker, I.G. & Duffull, S.B. An in silico knockout model for gastrointestinal absorption using a systems pharmacology approach – development and application to ketones. PLoS One 11, e0163795 (2016). 27685985 PMC5042539
  20. [26]Anderson, B.J. & Holford, N.H. Mechanism‐based concepts of size and maturity in pharmacokinetics. Annu. Rev. Pharmacol. Toxicol. 48, 303– 332 (2008). 17914927

Authors
Duffull, S.
Affiliations
Otago Pharmacometrics Group, School of Pharmacy, University of Otago Dunedin New Zealand
Venue
CPT: Pharmacometrics & Systems Pharmacology
Publisher
Wiley
Published
2016-11-12
Volume
5
Issue
12
Pages
649-655
ISSN
2163-8306 (ISSN-L)
OpenAlex
W2554930269
Cited by
3
References
25
Citations by year
2022: 1 · 2019: 1 · 2018: 1
FWCI
3.51
Type
journal article
Language
en
Open access
Locations
  • CPT Pharmacometrics & Systems Pharmacology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Arts and Humanities › History and Philosophy of Science › Philosophy and History of Science
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
systems pharmacology, pharmacometrics, model integration, falsifiability, deductive reasoning, mathematical biology, philosophy of science
MeSH terms
Computer Simulation, Humans, Models, Theoretical, Pharmacology, Clinical, Systems Analysis, Systems Integration, Systems Biology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review